Literature DB >> 7613020

Antipsychotics in older patients. A safety perspective.

B G Pollock1, B H Mulsant.   

Abstract

Age is a major source of variation in drug response. Social, medical and physiological heterogeneity intertwines to complicate geriatric pharmacotherapy. Inappropriate and excessive use of medication may be the most significant treatable health problem in the elderly. Older people are especially sensitive to antipsychotics, which are disproportionately prescribed to them. Antipsychotic side effects and adverse reactions are intensified and protean in an older population, ranging from disabling to deadly. It is therefore essential that the use of antipsychotics be based on clear indications, guided by knowledge of both age-related and individual determinants of drug clearance and action. Prospective and frequent assessments for adverse effects are also essential.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7613020     DOI: 10.2165/00002512-199506040-00006

Source DB:  PubMed          Journal:  Drugs Aging        ISSN: 1170-229X            Impact factor:   3.923


  110 in total

Review 1.  The role of pimozide in clinical psychiatry: a review.

Authors:  L A Opler; S S Feinberg
Journal:  J Clin Psychiatry       Date:  1991-05       Impact factor: 4.384

Review 2.  Review: drug-induced parkinsonism in elderly patients.

Authors:  J A Wilson; W J MacLennan
Journal:  Age Ageing       Date:  1989-05       Impact factor: 10.668

3.  Risk factors for falls among elderly persons living in the community.

Authors:  M E Tinetti; M Speechley; S F Ginter
Journal:  N Engl J Med       Date:  1988-12-29       Impact factor: 91.245

4.  Neuroleptics and the elderly.

Authors:  C A Peabody; M D Warner; H A Whiteford; L E Hollister
Journal:  J Am Geriatr Soc       Date:  1987-03       Impact factor: 5.562

5.  Prospective study of tardive dyskinesia incidence in the elderly.

Authors:  B L Saltz; M G Woerner; J M Kane; J A Lieberman; J M Alvir; K J Bergmann; K Blank; J Koblenzer; K Kahaner
Journal:  JAMA       Date:  1991-11-06       Impact factor: 56.272

6.  Oxidative stress in some dementia types.

Authors:  E Roche; D Romero-Alvira
Journal:  Med Hypotheses       Date:  1993-06       Impact factor: 1.538

7.  Serum concentration and elimination from serum of thioridazine in psychiatric patients.

Authors:  R Axelsson; E Mårtensson
Journal:  Curr Ther Res Clin Exp       Date:  1976-02

8.  Debrisoquine hydroxylation phenotyping in geriatric psychopharmacology.

Authors:  B G Pollock; J M Perel; L P Altieri; M Kirshner; A L Fasiczka; P R Houck; C F Reynolds
Journal:  Psychopharmacol Bull       Date:  1992

Review 9.  Behavioral toxicity of antipsychotic drugs.

Authors:  T Van Putten; S R Marder
Journal:  J Clin Psychiatry       Date:  1987-09       Impact factor: 4.384

Review 10.  Neuroleptics: effects on neuropsychological function in chronic schizophrenic patients.

Authors:  G Cassens; A K Inglis; P S Appelbaum; T G Gutheil
Journal:  Schizophr Bull       Date:  1990       Impact factor: 9.306

View more
  4 in total

Review 1.  New atypical antipsychotics. Experience and utility in the elderly.

Authors:  R A Sweet; B G Pollock
Journal:  Drugs Aging       Date:  1998-02       Impact factor: 3.923

Review 2.  Antipsychotic medications and the elderly: effects on cognition and implications for use.

Authors:  M J Byerly; M T Weber; D L Brooks; L R Snow; M A Worley; E Lescouflair
Journal:  Drugs Aging       Date:  2001       Impact factor: 3.923

3.  The role of antipsychotics in treating delirium.

Authors:  Larry Tune
Journal:  Curr Psychiatry Rep       Date:  2002-06       Impact factor: 5.285

4.  Drug use and low blood pressure in the elderly: a study of data from the kungsholmen project.

Authors:  G Passare; Z Guo; B Winblad; J Fastbom
Journal:  Clin Drug Investig       Date:  1998       Impact factor: 2.859

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.